Full Press Release Details
March 30, 2022, 4:30 PM EST / 22:30 CET
MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference
IRVINE, CA, and HERSTAL, BELGIUM – March 30, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, CEO, will participate in the 14th Annual Kempen Life Sciences Conference which will take place in Amsterdam on April 20, 2022.
The Company will be available for 1x1 meetings and invites investors to contact their Kempen representative for further information.
2022 Updated Reporting Calendar
April 27, 2022: Q1-2022 business update
May 25, 2022: Annual general shareholders’ meeting
August 25, 2022: Publication of H1-2022 results
October 27, 2022: Q3-2022 business update
For more information:
| MDxHealth info@mdxhealth.com | |
| LifeSci Advisors (IR & PR) US: +1 949 271 9223 ir@mdxhealth.com |
NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx, SelectMDx, AS-MDx and MonitorMDx are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.
MDxHealth Press Release
Attachments
MDxHealth Press Release...